Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SKB patents several series of vitronectin receptor antagonists

Sep. 11, 1997

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Sep. 10, 1997

PolyHeme blood substitute advances to phase III

Sep. 10, 1997

Osteoprotegerin: new polypeptide for bone diseases

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Genentech discontinues IGF-I development for type I and II diabetes

Sep. 8, 1997

GH secretagogues claimed by Novo Nordisk

Sep. 8, 1997

Sequana and Glaxo Wellcome near discovery of diabetes genes

Sep. 8, 1997

ENDOcare's device for abnormal uterine bleeding enters clinical trials

Sep. 8, 1997

Vertex and Alpha Therapeutic end hemoglobin collaboration

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...